Dewpoint Therapeutics
Biotechnology ResearchMassachusetts, United States51-200 Employees
Dewpoint Therapeutics is a biotechnology research company that applies the biology of biomolecular condensates to drug discovery. Based in Boston, Massachusetts, the firm pursues therapies across oncology, neurodegeneration, cardiopulmonary, and virology indications, through collaborations with leading global partners. Its partnerships include Bayer, Novo Nordisk, Evotec, and Chemify, supporting a broad development program. The company aims to translate condensate biology into treatments for diseases that have been difficult to address. In 2026, it presented preclinical data at the AACR Annual Meeting highlighting an oral condensate modulator intended to disrupt MYC-driven cancers.